Insulin-aspart/Insulin-detemirLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2039卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72711-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：274 / 274

相关论文

共 50 条

[21] Insulin-aspart/insulin-protamine-aspartMultifocal lipoatrophy: case report
Reactions Weekly, 2021, 1852 (1) : 240 - 240
[22] Insulin-aspart/insulin-protamine-aspart overdoseVarious toxicities secondary to overdose: case report
Reactions Weekly, 2022, 1914 (1) : 261 - 261
[23] Insulin-aspart/insulin-glargineLocalised insulin-derived amyloidosis: case report
Reactions Weekly, 2020, 1803 (1) : 138 - 138
[24] Insulin-aspart/insulin-detemirHypoglycaemia following intentional overdose: case report
Reactions Weekly, 2022, 1932 (1) : 330 - 330
[25] Insulin-aspart/Insulin-glargine overdoseInjection site swelling: case report
Reactions Weekly, 2014, 1527 (1) : 124 - 124
[26] Glucose/insulin-aspart/insulin-glargineHypoglycaemia and liver dysfunction: case report
Reactions Weekly, 2016, 1602 (1) : 135 - 135
[27] Insulin-aspart/insulin-suspension-isophane/insulin-lisproWorsening of obesity: case report
Reactions Weekly, 2017, 1658 (1) : 249 - 249
[28] Insulin-aspart/insulin-glargine/insulin-lisproExogenous insulin antibody syndrome: case report
Reactions Weekly, 2020, 1804 (1) : 159 - 159
[29] Insulin-aspart/Insulin-glargineHypoglycaemia
Reactions Weekly, 2024, 2005 (1) : 456 - 456
[30] Insulin-aspart/Insulin-glargine/OctreotideSevere hypoglycaemia following drug overdose and lack of efficacy: case report
Reactions Weekly, 2024, 2028 (1) : 250 - 250

← 1 2 3 4 5 →